Finally, the HA PD-1 Ig and RT combination therapy promoted a protective immunological memory response characterized by an accumulation of CD8 effector memory T cells (TEM), and CD8 central memory T cells (TCM) in “cured” mice that were re-challenged with a second injection of tumor cells 57 days after the initial tumor challenge. This evidence concerns the gene PDCD1 and neoplasm.